MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Spiral Analysis is a Promising Biomarker in LRRK2 G2019S carriers

    R. Ortega, M. Pullman, A. Glickman, I. Perera, M. San Luciano, A. Mirelman, C. Pont-Sunyer, N. Giladi, E. Tolosa, Q. Yu, S. Bressman, S. Pullman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To assess whether harboring a LRRK2 G2019S mutation is associated with abnormalities in spiral drawing, including in mutation carriers with Parkinson Disease (PD) as…
  • 2017 International Congress

    Expression of OX40 and OX40 serum level in patients with Parkinson’s disease

    F. Alsahebfosoul, A. SeyedJoodaki, N. Eskandari, V. Shaygannejad, M. Salehi, M. Kazemi, M.T. Kardi, O. Mirmossayeb (Isfahan, Islamic Republic of Iran)

    Objective: Study the expression of OX40 gene and its serum levels  could be measured to predict and confirm diagnosis of Parkinson's disease and help develop new…
  • 2017 International Congress

    Suicidality in Parkinson’s Disease: A Case Control Study

    M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga (Ankara, Turkey)

    Objective: To investigate suicidality in Parkinson's disease (PD) by a case control study Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless,…
  • 2017 International Congress

    Sports or no sports – is that the question in PD?

    M. Strothjohann, P. Kostopoulos, F. Weber (Bad Camberg, Germany)

    Objective: A multitude of risk factors or protective factors in developing Parkinson’s Disease (PD) are under discussion, as caffeine consumption or smoking ..  Background: Frequent physical activity…
  • 2017 International Congress

    Association of vitamin D deficiency in Parkinson disease

    A. MUJTABA, N. ALSOMALI, A. ALSHAMRANI, S. MARAR, T. Alayan, J. BAJWA (RIYADH, Saudi Arabia)

    Objective: To identify the association between vitamin D deficiency and  PD in an Arab cohort.  Background: A growing body of evidence suggests that vitamin D…
  • 2017 International Congress

    The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis

    J.R. Perez-Sanchez, B. DeLaCasa-Fages, A. Contreras, J.M. Velázquez, A. Muñoz-González, F. Grandas (Madrid, Spain)

    Objective: To study and compare in healthy subjects and patients with Parkinson´s disease (PD) the destabilizing force needed to reach the limit of stability (LoS), the displacements of…
  • 2017 International Congress

    Slow Release Fixed Dose Combination of Low Doses Pramipexole and Rasagiline (P2B001) for the Treatment of Early Parkinson’s Disease (PD).

    C. Olanow, K. Kieburtz, N. Livnah (New York, NY, USA)

    Objective: Evaluation of the efficacy and safety of a slow release low dose combination of pramipexole (PPX) and rasagiline (RAS) (P2B001) in a prospective double-blind…
  • 2017 International Congress

    Comparison of hand functions between people with Parkinson’s disease and healthy subjects

    M. Mak, I. Wong (Hong Kong, Hong Kong)

    Objective: To compare the hand functions between Parkinson’s Disease (PD) and healthy subjects using objective and subjective measures; and to establish the correlations among outcome…
  • 2017 International Congress

    Spinal cord stimulation as therapeutic option in gait disorder in Parkinson disease.

    H. Cécile, D'H. Vincent, B.M. MALEK, p.-k. nathalie, t. Jean-Batiste, Z. MARC, B. Jean-Philippe (PARIS, France)

    Objective: We aim to study the effect of spinal cord stimulation over gait in parkinson disease without pain nor neuropathy. Background: Axial symptoms in the course…
  • 2017 International Congress

    Levodopa/carbidopa Intestinal Gel Can Improve Both Motor and Non-Motor Experiences of Daily Living in Parkinson’s Disease: An Open-Label Study

    N. Kovacs, A. Juhász, Z. Aschermann, P. Ács, J. Janszky, M. Kovács, A. Makkos, M. Harmat, D. Tényi, K. Katádi, S. Komoly, A. Takáts, A. Tóth, H. Nagy, P. Klivényi, G. Dibó, L. Dézsi, D. Zádori, Á. Annus, L. Vécsei, L. Varannai (Pécs, Hungary)

    Objective: : Our aim was to determine if the MDS-UPDRS and UDysRS could detect improvement in the experiences of daily living following 1-year LCIG treatment.…
  • « Previous Page
  • 1
  • …
  • 302
  • 303
  • 304
  • 305
  • 306
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley